Written answers
Wednesday, 13 October 2021
Department of Health
Medicinal Products
Seán Canney (Galway East, Independent)
Link to this: Individually | In context | Oireachtas source
207. To ask the Minister for Health when he will establish a Ministerial stakeholder group as agreed by him in November 2020 to review and strengthen current risk reduction measures for women of childbearing potential prescribed valproate; and if he will make a statement on the matter. [49978/21]
Emer Higgins (Dublin Mid West, Fine Gael)
Link to this: Individually | In context | Oireachtas source
229. To ask the Minister for Health if he will report on the progress in establishing a Ministerial stakeholder group as agreed in November 2020 to review and strengthen current risk reduction measures around the use of sodium valproate to treat epilepsy in women of child-bearing potential; and if he will make a statement on the matter. [50103/21]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
I propose to take Questions Nos. 207 and 229 together.
Details of the proposed stakeholder group referred to by the Deputy are currently under consideration by officials within the Department of Health.
No comments